DB
GDRX icon

Dmitry Balyasny’s GoodRx Holdings GDRX Stock Holding History

Dmitry Balyasny’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-370,310
Closed -$726K – 3186
2026
Q1 		$726K Sell
370,310
-78,722
-18% -$185K ﹤0.01% 2211
2025
Q4 		$1.22M Buy
449,032
+220,012
+96% +$722K ﹤0.01% 2098
2025
Q3 		$969K Sell
229,020
-17,197
-7% -$75.6K ﹤0.01% 2125
2025
Q2 		$1.23M Sell
246,217
-1,644
-0.7% -$7.14K ﹤0.01% 1967
2025
Q1 		$1.09M Buy
247,861
+60,831
+33% +$286K ﹤0.01% 1952
2024
Q4 		$870K Buy
+187,030
New +$1.03M ﹤0.01% 1993
2024
Q1 		– Sell
-85,527
Closed -$573K – 2793
2023
Q4 		$573K Buy
85,527
+27,115
+46% +$153K ﹤0.01% 1895
2023
Q3 		$329K Sell
58,412
-368,376
-86% -$2.46M ﹤0.01% 1878
2023
Q2 		$2.36M Buy
+426,788
New +$2.3M 0.01% 1330

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dmitry Balyasny's GDRX Position: Q2 2026 in Review

Dmitry Balyasny sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 370,310 shares — an estimated $726K sold.

Dmitry Balyasny first reported a position in GDRX in Q2 2023 and held it in 9 quarters. The position peaked at $2.36M in Q2 2023. 159 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Dmitry Balyasny reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 370,310 GoodRx Holdings shares in Q2 2026, an estimated $726K.
  • Dmitry Balyasny first reported a position in GoodRx Holdings in Q2 2023 and held it in 9 quarters.
  • Dmitry Balyasny's GoodRx Holdings position peaked at $2.36M in Q2 2023.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.